JP Patent
JP4292570B2 — N−置換ピラゾール−o−グリコシド誘導体及びそれらを含有する糖尿病治療薬
Assigned to Ajinomoto Co Inc · Expires 2009-07-08 · 17y expired
What this patent protects
Patent listed against Farxiga.
Drugs covered by this patent
- Farxiga (DAPAGLIFLOZIN) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.